<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37246961</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2023</Year><Month>Jun</Month><Day>06</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>The Kinetics of Anti-SARS-CoV-2 Antibodies in Pediatric Patients and the Characterization of Post-COVID-19 Condition at 6 Months After Infection: Protocol for a Longitudinal Observational Study.</ArticleTitle><Pagination><StartPage>e43344</StartPage><MedlinePgn>e43344</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e43344</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/43344</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Data regarding the kinetics of anti-SARS-CoV-2 antibodies and information about post-COVID-19 condition (colloquially known as "long COVID") in children are scarce, especially in low-income countries. Even though cases of COVID-19 in children are less prevalent than adults, post-COVID-19 condition cases in children are high and have a burden that may impact their growth and development. There are other features of antibody kinetics in connection with SARS-CoV-2 infection that are yet unknown as of this writing, especially in children following infection. Furthermore, the long-term results, risk factors, and underlying pathophysiology are still uncertain. To better understand post-COVID-19 condition in children, it is necessary to further investigate the impact of clinically significant factors such multisystem inflammatory syndrome and disease severity among hospitalized survivors through their SARS-CoV-2 antibody response.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aim to analyze anti-receptor-binding domain SARS-CoV-2 immunoglobulin G antibodies over time and characterize the signs and symptoms of post-COVID-19 condition in pediatric patients at the time of diagnosis and at 2 weeks and 1, 3, and 6 months following infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a longitudinal observational study in Indonesia. Pediatric patients diagnosed with COVID-19 by positive molecular assay using nasopharyngeal swab will be tested for anti-SARS-CoV-2 antibodies using the Roche Elecsys Anti-SARS-CoV-2 S assay at the time of diagnosis and at 2 weeks and 1, 3, and 6 months following infection. Antibody titer data will be reported as means and SDs. The respondents' signs and symptoms will be observed up to 6 months after the onset of infection, including the vaccination event, reinfection, rehospitalization, and mortality. The clinical features will be reported as frequencies and percentages.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Participant enrollment began in February 2022. As of September 30, 2022, a total of 58 patients were enrolled. After data collection, results are expected to be analyzed in August 2023.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study will allow us to know the kinetics of anti-receptor-binding domain SARS-CoV-2 immunoglobulin G antibodies and data regarding post-COVID-19 condition up to 6 months following infection in the Indonesian pediatric population. Furthermore, this study has the potential to serve as a foundation for government decisions about vaccination programs and prevention measures.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/43344.</AbstractText><CopyrightInformation>&#xa9;Eggi Arguni, Fatia Murni Chamida, Ratni Indrawanti, Desy Rusmawatiningtyas, Yunika Puspa Dewi, Ida Safitri Laksanawati. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 06.06.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Arguni</LastName><ForeName>Eggi</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7462-7904</Identifier><AffiliationInfo><Affiliation>Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chamida</LastName><ForeName>Fatia Murni</ForeName><Initials>FM</Initials><Identifier Source="ORCID">0000-0002-3539-5570</Identifier><AffiliationInfo><Affiliation>Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Indrawanti</LastName><ForeName>Ratni</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2588-612X</Identifier><AffiliationInfo><Affiliation>Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusmawatiningtyas</LastName><ForeName>Desy</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1676-8383</Identifier><AffiliationInfo><Affiliation>Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dewi</LastName><ForeName>Yunika Puspa</ForeName><Initials>YP</Initials><Identifier Source="ORCID">0000-0001-5559-6989</Identifier><AffiliationInfo><Affiliation>Department of Integrated Laboratory, Dr Sardjito General Hospital, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laksanawati</LastName><ForeName>Ida Safitri</ForeName><Initials>IS</Initials><Identifier Source="ORCID">0000-0003-3635-9552</Identifier><AffiliationInfo><Affiliation>Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">antibodies</Keyword><Keyword MajorTopicYN="N">anti&#x2013;SARS-CoV-2 antibodies</Keyword><Keyword MajorTopicYN="N">kinetics</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pediatric patient</Keyword><Keyword MajorTopicYN="N">post&#x2013;COVID-19 condition</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>13</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>10</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37246961</ArticleId><ArticleId IdType="pmc">PMC10246664</ArticleId><ArticleId IdType="doi">10.2196/43344</ArticleId><ArticleId IdType="pii">v12i1e43344</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li Qun, Guan Xuhua, Wu Peng, Wang Xiaoye, Zhou Lei, Tong Yeqing, Ren Ruiqi, Leung Kathy S M, Lau Eric H Y, Wong Jessica Y, Xing Xuesen, Xiang Nijuan, Wu Yang, Li Chao, Chen Qi, Li Dan, Liu Z, Zhao Jing, Liu Man, Tu Wenxiao, Chen Chuding, Jin Lianmei, Yang Rui, Wang Qi, Zhou Suhua, Wang Rui, Liu Hui, Luo Yinbo, Liu Yuan, Shao Ge, Li Huan, Tao Zhongfa, Yang Yang, Deng Zhiqiang, Liu Boxi, Ma Zhitao, Zhang Yanping, Shi Guoqing, Lam Tommy T Y, Wu Joseph T, Gao George F, Cowling Benjamin J, Yang Bo, Leung Gabriel M, Feng Zijian. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199&#x2013;1207. doi: 10.1056/NEJMoa2001316. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan BS, Nambiar V. COVID-19: an insight into SARS-CoV-2 pandemic originated at Wuhan City in Hubei Province of China. J Infect Dis Epidemiol. 2020 Jul 18;6(4):146. doi: 10.23937/2474-3658/1510146.</Citation><ArticleIdList><ArticleId IdType="doi">10.23937/2474-3658/1510146</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 disease in children and adolescents. World Health Organization. 2021. Sep 29,  [2022-04-14].  
 https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Children_and_adolescents-2021.1
.</Citation></Reference><Reference><Citation>American AOP. Children and COVID-19: state-level data report. American Academy of Pediatrics. 2022.  [2022-04-14].  
 https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report
.</Citation></Reference><Reference><Citation>Pudjiadi AH, Putri ND, Sjakti HA, Yanuarso PB, Gunardi H, Roeslani RD, Pasaribu AD, Nurmalia LD, Sambo CM, Ugrasena IDG, Soeroso S, Firman A, Muryawan H, Setyanto DB, Citraresmi E, Effendi JA, Habibah L, Octaviantie PD, Utami INA, Prawira Y, Kaswandani N, Alam A, Kadafi KT, Pulungan AB. Pediatric COVID-19: report from Indonesian Pediatric Society data registry. Front Pediatr. 2021 Sep 23;9:716898. doi: 10.3389/fped.2021.716898. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.716898</ArticleId><ArticleId IdType="pmc">PMC8495320</ArticleId><ArticleId IdType="pubmed">34631619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali K, Berman G, Zhou H, Deng W, Faughnan V, Coronado-Voges M, Ding B, Dooley J, Girard B, Hillebrand W, Pajon R, Miller JM, Leav B, McPhee R. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. N Engl J Med. 2021 Dec 09;385(24):2241&#x2013;2251. doi: 10.1056/NEJMoa2109522. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109522</ArticleId><ArticleId IdType="pmc">PMC8385554</ArticleId><ArticleId IdType="pubmed">34379915</ArticleId></ArticleIdList></Reference><Reference><Citation>Renk H, Dulovic A, Seidel Alina, Becker Matthias, Fabricius Dorit, Zernickel Maria, Junker Daniel, Gro&#xdf; R&#xfc;diger, M&#xfc;ller Janis, Hilger Alexander, Bode Sebastian F N, Fritsch Linus, Frieh Pauline, Haddad Anneke, G&#xf6;rne Tessa, Remppis Jonathan, Ganzemueller Tina, Dietz Andrea, Huzly Daniela, Hengel Hartmut, Kaier Klaus, Weber Susanne, Jacobsen Eva-Maria, Kaiser Philipp D, Traenkle Bjoern, Rothbauer Ulrich, Stich Maximilian, T&#xf6;nshoff Burkhard, Hoffmann Georg F, M&#xfc;ller Barbara, Ludwig Carolin, Jahrsd&#xf6;rfer Bernd, Schrezenmeier Hubert, Peter Andreas, H&#xf6;rber Sebastian, Iftner Thomas, M&#xfc;nch Jan, Stamminger Thomas, Gro&#xdf; Hans-J&#xfc;rgen, Wolkewitz Martin, Engel Corinna, Liu Weimin, Rizzi Marta, Hahn Beatrice H, Henneke Philipp, Franz Axel R, Debatin Klaus-Michael, Schneiderhan-Marra Nicole, Janda Ales, Elling Roland. Robust and durable serological response following pediatric SARS-CoV-2 infection. Nat Commun. 2022 Jan 10;13(1):128. doi: 10.1038/s41467-021-27595-9. doi: 10.1038/s41467-021-27595-9.10.1038/s41467-021-27595-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27595-9</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-27595-9</ArticleId><ArticleId IdType="pmc">PMC8748910</ArticleId><ArticleId IdType="pubmed">35013206</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo AD, Schneeweiss-Gleixner Mathias, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021 Jan 29;41(1):20&#x2013;32. doi: 10.1111/liv.14730. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14730</ArticleId><ArticleId IdType="pmc">PMC7753756</ArticleId><ArticleId IdType="pubmed">33190346</ArticleId></ArticleIdList></Reference><Reference><Citation>Premkumar L, Segovia-Chumbez B, Jadi R, Martinez DR, Raut R, Markmann A, Cornaby C, Bartelt L, Weiss S, Park Y, Edwards CE, Weimer E, Scherer EM, Rouphael N, Edupuganti S, Weiskopf D, Tse LV, Hou YJ, Margolis D, Sette A, Collins MH, Schmitz J, Baric RS, de Silva AM. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci Immunol. 2020 Jun 11;5(48):eabc8413. doi: 10.1126/sciimmunol.abc8413. 
 
5/48/eabc8413</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc8413?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1126/sciimmunol.abc8413</ArticleId><ArticleId IdType="pmc">PMC7292505</ArticleId><ArticleId IdType="pubmed">32527802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonfante F, Costenaro P, Cantarutti A, di Chiara Costanza, Bortolami Alessio, Petrara Maria Raffaella, Carmona Francesco, Pagliari Matteo, Cosma Chiara, Cozzani Sandra, Mazzetto Eva, di Salvo Giovanni, da Dalt Liviana, Palma Paolo, Barzon Luisa, Corrao Giovanni, Terregino Calogero, Padoan Andrea, Plebani Mario, De Rossi Anita, Don&#xe0; Daniele, Giaquinto Carlo. Mild SARS-CoV-2 infections and neutralizing antibody titers. Pediatrics. 2021 Sep;148(3):e2021052173. doi: 10.1542/peds.2021-052173. doi: 10.1542/peds.2021-052173.peds.2021-052173</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-052173</ArticleId><ArticleId IdType="doi">10.1542/peds.2021-052173</ArticleId><ArticleId IdType="pubmed">34158312</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang HS, Costa V, Racine-Brzostek SE, Acker Karen P, Yee Jim, Chen Zhengming, Karbaschi Mohsen, Zuk Robert, Rand Sophie, Sukhu Ashley, Klasse P J, Cushing Melissa M, Chadburn Amy, Zhao Zhen. Association of age with SARS-CoV-2 antibody response. JAMA Netw Open. 2021 Mar 01;4(3):e214302. doi: 10.1001/jamanetworkopen.2021.4302. 
 
2777743</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.4302</ArticleId><ArticleId IdType="pmc">PMC7985726</ArticleId><ArticleId IdType="pubmed">33749770</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg SP, Connors TJ, Zhu Y, Baldwin MR, Lin W, Wontakal S, Szabo PA, Wells SB, Dogra P, Gray J, Idzikowski E, Stelitano D, Bovier FT, Davis-Porada J, Matsumoto R, Poon MML, Chait M, Mathieu C, Horvat B, Decimo D, Hudson KE, Zotti FD, Bitan ZC, La Carpia F, Ferrara SA, Mace E, Milner J, Moscona A, Hod E, Porotto M, Farber DL. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 2021 Jan 05;22(1):25&#x2013;31. doi: 10.1038/s41590-020-00826-9. 
 
10.1038/s41590-020-00826-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00826-9</ArticleId><ArticleId IdType="pmc">PMC8136619</ArticleId><ArticleId IdType="pubmed">33154590</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner RM, Ward JL, Hudson LD, Ashe M, Patel SV, Hargreaves D, Whittaker E. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch Dis Child. 2020 Dec 17;106(8):802&#x2013;807. doi: 10.1136/archdischild-2020-320972. 
 
archdischild-2020-320972</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320972</ArticleId><ArticleId IdType="pubmed">33334728</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Zhang S, Zhang R, Chen X, Wang Y, Zhu C. Epidemiological and clinical characteristics of COVID-19 in children: a systematic review and meta-analysis. Front Pediatr. 2020 Nov 2;8:591132. doi: 10.3389/fped.2020.591132. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.591132</ArticleId><ArticleId IdType="pmc">PMC7667131</ArticleId><ArticleId IdType="pubmed">33224909</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, Murray B, Kl&#xe4;ser Kerstin, Kerfoot E, Chen L, Deng J, Hu C, Selvachandran S, Read K, Capdevila Pujol J, Hammers A, Spector TD, Ourselin S, Steves CJ, Modat M, Absoud M, Duncan EL. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021 Oct;5(10):708&#x2013;718. doi: 10.1016/S2352-4642(21)00198-X. 
 
S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett SD, Zhang AXD, O'Mahoney LL, Stephenson TJ, Ladhani SN, de Stavola BL, Viner RM, Swann OV. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2022 Feb;84(2):158&#x2013;170. doi: 10.1016/j.jinf.2021.11.011. 
 
S0163-4453(21)00555-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S, Palm Pernille, Nygaard U, Bundgaard H, Petersen Maria Nivi Schmidt, Rosenkilde Siri, Thorsted Anne Bonde, Ersb&#xf8;ll Annette Kj&#xe6;r, Thygesen Lau Casper, Nielsen Susanne Dam, Vinggaard Christensen Anne. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 2022 Sep;6(9):614&#x2013;623. doi: 10.1016/S2352-4642(22)00154-7. 
 
S2352-4642(22)00154-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pmc">PMC9221683</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId></ArticleIdList></Reference><Reference><Citation>Fainardi V, Meoli A, Chiopris G, Motta M, Skenderaj K, Grandinetti R, Bergomi A, Antodaro F, Zona S, Esposito S. Long COVID in children and adolescents. Life (Basel) 2022 Feb 14;12(2):285. doi: 10.3390/life12020285. 
 
life12020285</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020285</ArticleId><ArticleId IdType="pmc">PMC8876679</ArticleId><ArticleId IdType="pubmed">35207572</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche DG. Elecsys Anti-SARS-CoV-2 S - instructions for use. Roche Diagnostics GmbH. 2022.  [2022-07-01].  
 https://www.fda.gov/media/144037/download
.</Citation></Reference><Reference><Citation>Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020 Apr 07;92(4):418&#x2013;423. doi: 10.1002/jmv.25681. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25681</ArticleId><ArticleId IdType="pmc">PMC7167049</ArticleId><ArticleId IdType="pubmed">31967327</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahar B, Jacquot Cyril, Mo Yunchuan D, DeBiasi Roberta L, Campos Joseph, Delaney Meghan. Kinetics of viral clearance and antibody production across age groups in children with severe acute respiratory syndrome coronavirus 2 infection. J Pediatr. 2020 Dec;227:31&#x2013;37.e1. doi: 10.1016/j.jpeds.2020.08.078. 
 
S0022-3476(20)31114-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.08.078</ArticleId><ArticleId IdType="pmc">PMC7468315</ArticleId><ArticleId IdType="pubmed">32891640</ArticleId></ArticleIdList></Reference><Reference><Citation>Post N, Eddy D, Huntley C, van Schalkwyk MCI, Shrotri M, Leeman D, Rigby S, Williams SV, Bermingham WH, Kellam P, Maher J, Shields AM, Amirthalingam G, Peacock SJ, Ismail SA. Antibody response to SARS-CoV-2 infection in humans: a systematic review. PLoS One. 2020 Dec 31;15(12):e0244126. doi: 10.1371/journal.pone.0244126. 
 
PONE-D-20-27927</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244126</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0244126</ArticleId><ArticleId IdType="pmc">PMC7775097</ArticleId><ArticleId IdType="pubmed">33382764</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA, Johnson L. Defining long COVID: going back to the start. Med. 2021 May 14;2(5):501&#x2013;504. doi: 10.1016/j.medj.2021.03.003. 
 
S2666-6340(21)00105-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.003</ArticleId><ArticleId IdType="pmc">PMC7992371</ArticleId><ArticleId IdType="pubmed">33786465</ArticleId></ArticleIdList></Reference><Reference><Citation>Smane L, Stars Inese, Pucuka Zanda, Roge Ieva, Pavare Jana. Persistent clinical features in paediatric patients after SARS-CoV-2 virological recovery: a retrospective population-based cohort study from a single centre in Latvia. BMJ Paediatr Open. 2020 Dec 29;4(1):e000905. doi: 10.1136/bmjpo-2020-000905. 
 
bmjpo-2020-000905</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjpo-2020-000905</ArticleId><ArticleId IdType="pmc">PMC7778738</ArticleId><ArticleId IdType="pubmed">34192185</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazi-Hoffnung L, Shmueli Einat, Ehrlich Shay, Ziv Adi, Bar-On Ophir, Birk Einat, Lowenthal Alexander, Prais Dario. Long COVID in children: observations from a designated pediatric clinic. Pediatr Infect Dis J. 2021 Dec 01;40(12):e509&#x2013;e511. doi: 10.1097/INF.0000000000003285. 
 
00006454-900000000-95712</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003285</ArticleId><ArticleId IdType="pmc">PMC8575093</ArticleId><ArticleId IdType="pubmed">34371507</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021 Jul 15;326(9):869&#x2013;71. doi: 10.1001/jama.2021.11880. 
 
2782164</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova Ekaterina, Bobkova Polina, Gamirova Aysylu, Shikhaleva Anastasia, Andreeva Margarita, Blyuss Oleg, El-Taravi Yasmin, DunnGalvin Audrey, Comberiati Pasquale, Peroni Diego G, Apfelbacher Christian, Genuneit Jon, Mazankova Lyudmila, Miroshina Alexandra, Chistyakova Evgeniya, Samitova Elmira, Borzakova Svetlana, Bondarenko Elena, Korsunskiy Anatoliy A, Konova Irina, Hanson Sarah Wulf, Carson Gail, Sigfrid Louise, Scott Janet T, Greenhawt Matthew, Whittaker Elizabeth A, Garralda Elena, Swann Olivia V, Buonsenso Danilo, Nicholls Dasha E, Simpson Frances, Jones Christina, Semple Malcolm G, Warner John O, Vos Theo, Olliaro Piero, Munblit Daniel, the Sechenov StopCOVID Research Team  Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022 Feb 3;59(2):2101341. doi: 10.1183/13993003.01341-2021. 
 
13993003.01341-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, Rumyantsev M, Gamirova A, Bairashevskaia A, Petrova P, Baimukhambetova D, Pikuza M, Abdeeva E, Filippova Y, Deunezhewa S, Nekliudov N, Bugaeva P, Bulanov N, Avdeev S, Kapustina V, Guekht A, DunnGalvin A, Comberiati P, Peroni DG, Apfelbacher C, Genuneit J, Reyes LF, Brackel CL, Fomin V, Svistunov AA, Timashev P, Mazankova L, Miroshina A, Samitova E, Borzakova S, Bondarenko E, Korsunskiy AA, Carson G, Sigfrid L, Scott JT, Greenhawt M, Buonsenso D, Semple M, Warner JO, Olliaro PL, Needham DM, Glybochko P, Butnaru D, Osmanov IM, Munblit D, Sechenov StopCOVID Research Team  Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12&#x2009;months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID) BMC Med. 2022 Jul 06;20(1):244. doi: 10.1186/s12916-022-02448-4. 
 
10.1186/s12916-022-02448-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>